中国自主研发的老年痴呆症药物完成了第三期临床试验
青岛希尼尔翻译咨询有限公司（www.sinosenior.com）整理发布 2018-7-21
青岛希尼尔翻译公司（www.sinosenior.com）2018年7月21日了解到：China’s
domestically-made new drug to treat Alzheimer’s disease completed its
phase 3 clinical trial on Tuesday, a breakthrough that marks the most
critical step in the drug development and the last test before entering
the market.
中国国内生产的治疗阿尔茨海默病的新药周二完成了第三期临床试验，这一突破标志着药物研发的关键一步，也是进入市场之前的最后一次试验。
The new drug, named “GV-971”, was co-developed by Ocean University of
China, Shanghai Institute of Materia Medica under Chinese Academy of
Sciences and Green Valley Pharmaceutical Co., Ltd, after 21 years’
efforts.
这种新药名为“GV-971”，经过21年的努力，由中国海洋大学、中国科学院上海药物研究所和绿色谷制药有限公司共同开发。
It was extracted from brown algae and targeted at patients with
mild-to-moderate Alzheimer’s. The phase 3 clinical trial was to testify
the effectiveness and security of the new drug to such patients.
它是从褐藻中提取出来的，针对的是轻度到中度老年痴呆症的患者。第三阶段临床试验是为了向这些患者证明新药的有效性和安全性。
After the 36-week trial, during which patients took 450 mg of this drug
orally twice a day, the drug was proved to meet the expectation in
improving patients’ cognitive function. Some became literate and were
able to write from illiteracy, showing an obvious effect, according to
the doctor in charge of the clinical trial.
在为期36周的试验中，患者每天两次口服该药物450毫克，实验证明该药物在改善患者认知功能方面达到了预期。据负责临床试验的医生说，有些人识字了，还能写字，显示出明显的效果。
In the latest research, GV-971 also showed its effectiveness in
restraining Alzheimer’s progression by regulating the immune system and
reducing neuro-inflammation.
在最新的研究中，GV-971还显示了它通过调节免疫系统和减少神经炎症来抑制阿尔茨海默病的进展。
Alzheimer’s disease is an irreversible, progressive brain disorder that
slowly destroys memory, thinking skills, and the ability to carry out
simple tasks. Roughly 48 million people globally have been affected by
it so far.
阿尔茨海默氏症是一种不可逆的、渐进性的大脑疾病，它会慢慢地破坏记忆、思维能力和完成简单任务的能力。到目前为止，全球约有4800万人受到影响。
The successful trial paves the way for the research of new drugs to
treat Alzheimer’s, playing a significant role in enhancing China’s
international status in the field of drug research innovation.
成功的试验为老年痴呆症新药的研究铺平了道路，对提高我国在药物研究创新领域的国际地位具有重要作用。
来源:中国国际电视台
---------------------------------------------------------------------------------------------------------------------------------------------------------------
青岛翻译公司 日照翻译 日照翻译公司 翻译公司 烟台翻译公司 烟台翻译公司 济宁翻译公司 泰安翻译公司 威海翻译公司 威海翻译公司
威海翻译公司 德州翻译公司 聊城翻译公司 滨州翻译公司 菏泽翻译公司 淄博翻译公司 枣庄翻译公司 东营翻译公司